Clinical Trial

Vitamin C and Hiprex in rUTI

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-11-26; most recent amendment 2026-02-10.
Trial Details
NCT Number NCT06710899
Lead Sponsor University Hospitals of North Midlands NHS Trust
Conditions Urinary Tract Infections
Enrollment 20 participants
Start Date 2027-01
Primary Completion 2027-08 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-11